Loading insider details...
Beta
Latest Form 4 (Aug 3, 2026): Sale of 525 GKOS shares, $88.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | GLAUKOS Corp (GKOS) | Sale | 525 | $88.0K |
| Jun 24, 2026 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jun 23, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 2,987 | n/a |
| May 4, 2026 | GLAUKOS Corp (GKOS) | Sale | 1,700 | $243.7K |
| Jan 8, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 623 | n/a |
| Dec 1, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,000 | n/a |
| Aug 27, 2025 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jun 2, 2025 | GLAUKOS Corp (GKOS) | Grant/Award | 461 | n/a |
| Aug 8, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jun 4, 2024 | GLAUKOS Corp (GKOS) | Grant/Award | 1,716 | n/a |